Markets:

Overview

News

Currencies

International

Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

23.75 +1.00 (+4.37%)

Streaming Delayed Price Updated: 10:25 AM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences, Inc. Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update

May 09, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

May 08, 2023

From Arcus Biosciences

Via Business Wire

Earnings Preview For Arcus Biosciences ↗

May 08, 2023

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

April 25, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Earnings Perspective: Return On Capital Employed ↗

March 06, 2023

Via Benzinga

Where Arcus Biosciences Stands With Analysts ↗

December 20, 2022

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

April 11, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

March 09, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences to Participate in the Barclays Global Healthcare Conference

March 02, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

February 28, 2023

From Arcus Biosciences

Via Business Wire

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Arcus Biosciences Announces New Employment Inducement Grants

February 24, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

February 09, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences to Participate at Upcoming Virtual Investor Events

February 06, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

January 24, 2023

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

January 10, 2023

From Arcus Biosciences

Via Business Wire

Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023? ↗

January 05, 2023

Merck has a number of efforts in the works to help avoid a Keytruda generics pitfall.

Via Investor's Business Daily

Arcus Biosciences Announces New Employment Inducement Grants

December 23, 2022

From Arcus Biosciences

Via Business Wire

Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review ↗

December 23, 2022

The market uptrend is under pressure.

Via Investor's Business Daily

Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data ↗

December 20, 2022

Although Gilead Sciences produced meaningful results regarding a lung cancer drug test, the competitive shortfall hurt GILD stock.

Via InvestorPlace

Dow Jumps 150 Points; Crude Oil Rises 1% ↗

December 20, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 20, 2022

Via Benzinga

Nasdaq Edges Lower; Gold Rises 1.5% ↗

December 20, 2022

U.S. stocks traded mixed midway through trading, with the S&P 500 and the Nasdaq Composite moving lower on Tuesday.

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday ↗

December 20, 2022

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche ↗

December 20, 2022

Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche.

Via Investor's Business Daily

US Stocks Edge Higher; Dow Rises 50 Points ↗

December 20, 2022

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 50 points on Tuesday.

Via Benzinga

Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients ↗

December 20, 2022

Via Benzinga

Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study

December 19, 2022

From Arcus Biosciences

Via Business Wire

Arcus Biosciences Announces New Employment Inducement Grants

December 09, 2022

From Arcus Biosciences

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.